398 related articles for article (PubMed ID: 29167197)
1. Rare PfCSP C-terminal antibodies induced by live sporozoite vaccination are ineffective against malaria infection.
Scally SW; Murugan R; Bosch A; Triller G; Costa G; Mordmüller B; Kremsner PG; Sim BKL; Hoffman SL; Levashina EA; Wardemann H; Julien JP
J Exp Med; 2018 Jan; 215(1):63-75. PubMed ID: 29167197
[TBL] [Abstract][Full Text] [Related]
2. Protective antibody and CD8+ T-cell responses to the Plasmodium falciparum circumsporozoite protein induced by a nanoparticle vaccine.
Kaba SA; McCoy ME; Doll TA; Brando C; Guo Q; Dasgupta D; Yang Y; Mittelholzer C; Spaccapelo R; Crisanti A; Burkhard P; Lanar DE
PLoS One; 2012; 7(10):e48304. PubMed ID: 23144750
[TBL] [Abstract][Full Text] [Related]
3. Antibodies elicited by Plasmodium falciparum circumsporozoite proteins lacking sequentially deleted C-terminal amino acids reveal mouse strain and epitopes specific differences.
Hayashi CTH; Cao Y; Zavala F; Simonyan H; Young CN; Kumar N
Vaccine; 2023 Nov; 41(46):6824-6833. PubMed ID: 37827967
[TBL] [Abstract][Full Text] [Related]
4. Protective effects of combining monoclonal antibodies and vaccines against the Plasmodium falciparum circumsporozoite protein.
Wang LT; Pereira LS; Kiyuka PK; Schön A; Kisalu NK; Vistein R; Dillon M; Bonilla BG; Molina-Cruz A; Barillas-Mury C; Tan J; Idris AH; Francica JR; Seder RA
PLoS Pathog; 2021 Dec; 17(12):e1010133. PubMed ID: 34871332
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of protective immune responses induced by the Plasmodium falciparum circumsporozoite protein-based, self-assembling protein nanoparticle vaccine.
McCoy ME; Golden HE; Doll TA; Yang Y; Kaba SA; Zou X; Gerbasi VR; Burkhard P; Lanar DE
Malar J; 2013 Apr; 12():136. PubMed ID: 23607541
[TBL] [Abstract][Full Text] [Related]
6. Evolution of protective human antibodies against Plasmodium falciparum circumsporozoite protein repeat motifs.
Murugan R; Scally SW; Costa G; Mustafa G; Thai E; Decker T; Bosch A; Prieto K; Levashina EA; Julien JP; Wardemann H
Nat Med; 2020 Jul; 26(7):1135-1145. PubMed ID: 32451496
[TBL] [Abstract][Full Text] [Related]
7. Immunization of Malaria-Preexposed Volunteers With PfSPZ Vaccine Elicits Long-Lived IgM Invasion-Inhibitory and Complement-Fixing Antibodies.
Zenklusen I; Jongo S; Abdulla S; Ramadhani K; Lee Sim BK; Cardamone H; Flannery EL; Nguyen T; Fishbaugher M; Steel RWJ; Betz W; Carmago N; Mikolajczak S; Kappe SHI; Hoffman SL; Sack BK; Daubenberger C
J Infect Dis; 2018 Apr; 217(10):1569-1578. PubMed ID: 29438525
[TBL] [Abstract][Full Text] [Related]
8. Liver-Directed AAV8 Booster Vaccine Expressing
Shahnaij M; Iyori M; Mizukami H; Kajino M; Yamagoshi I; Syafira I; Yusuf Y; Fujiwara K; Yamamoto DS; Kato H; Ohno N; Yoshida S
Front Immunol; 2021; 12():612910. PubMed ID: 34248928
[TBL] [Abstract][Full Text] [Related]
9. Bridging Computational Vaccinology and Vaccine Development Through Systematic Identification, Characterization, and Downselection of Conserved and Variable Circumsporozoite Protein CD4 T Cell Epitopes From Diverse
Noe AR; Terry FE; Schanen BC; Sassano E; Hindocha P; Phares TW; Moise L; Christen JM; Tucker KD; Kotraiah V; Drake DR; Martin WD; De Groot AS; Gutierrez GM
Front Immunol; 2021; 12():689920. PubMed ID: 34168657
[TBL] [Abstract][Full Text] [Related]
10. A high-affinity antibody against the CSP N-terminal domain lacks Plasmodium falciparum inhibitory activity.
Thai E; Costa G; Weyrich A; Murugan R; Oyen D; Flores-Garcia Y; Prieto K; Bosch A; Valleriani A; Wu NC; Pholcharee T; Scally SW; Wilson IA; Wardemann H; Julien JP; Levashina EA
J Exp Med; 2020 Nov; 217(11):. PubMed ID: 32790871
[TBL] [Abstract][Full Text] [Related]
11. IgG2 antibodies against a clinical grade Plasmodium falciparum CSP vaccine antigen associate with protection against transgenic sporozoite challenge in mice.
Schwenk R; DeBot M; Porter M; Nikki J; Rein L; Spaccapelo R; Crisanti A; Wightman PD; Ockenhouse CF; Dutta S
PLoS One; 2014; 9(10):e111020. PubMed ID: 25343487
[TBL] [Abstract][Full Text] [Related]
12. Down-selecting circumsporozoite protein-based malaria vaccine: A comparison of malaria sporozoite challenge model.
Amelia F; Iyori M; Emran TB; Yamamoto DS; Genshi K; Otsuka H; Onoue Y; Yusuf Y; Islam A; Yoshida S
Parasite Immunol; 2019 May; 41(5):e12624. PubMed ID: 30883819
[TBL] [Abstract][Full Text] [Related]
13. Enhanced immunity to Plasmodium falciparum circumsporozoite protein (PfCSP) by using Salmonella enterica serovar Typhi expressing PfCSP and a PfCSP-encoding DNA vaccine in a heterologous prime-boost strategy.
Chinchilla M; Pasetti MF; Medina-Moreno S; Wang JY; Gomez-Duarte OG; Stout R; Levine MM; Galen JE
Infect Immun; 2007 Aug; 75(8):3769-79. PubMed ID: 17502396
[TBL] [Abstract][Full Text] [Related]
14. Natural Parasite Exposure Induces Protective Human Anti-Malarial Antibodies.
Triller G; Scally SW; Costa G; Pissarev M; Kreschel C; Bosch A; Marois E; Sack BK; Murugan R; Salman AM; Janse CJ; Khan SM; Kappe SHI; Adegnika AA; Mordmüller B; Levashina EA; Julien JP; Wardemann H
Immunity; 2017 Dec; 47(6):1197-1209.e10. PubMed ID: 29195810
[TBL] [Abstract][Full Text] [Related]
15. A highly infectious Plasmodium yoelii parasite, bearing Plasmodium falciparum circumsporozoite protein.
Zhang M; Kaneko I; Tsao T; Mitchell R; Nardin EH; Iwanaga S; Yuda M; Tsuji M
Malar J; 2016 Apr; 15():201. PubMed ID: 27068454
[TBL] [Abstract][Full Text] [Related]
16. The P. falciparum CSP repeat region contains three distinct epitopes required for protection by antibodies in vivo.
Flores-Garcia Y; Wang LT; Park M; Asady B; Idris AH; Kisalu NK; Muñoz C; Pereira LS; Francica JR; Seder RA; Zavala F
PLoS Pathog; 2021 Nov; 17(11):e1010042. PubMed ID: 34748617
[TBL] [Abstract][Full Text] [Related]
17. Proteolytic Cleavage of the Plasmodium falciparum Circumsporozoite Protein Is a Target of Protective Antibodies.
Espinosa DA; Gutierrez GM; Rojas-López M; Noe AR; Shi L; Tse SW; Sinnis P; Zavala F
J Infect Dis; 2015 Oct; 212(7):1111-9. PubMed ID: 25762791
[TBL] [Abstract][Full Text] [Related]
18. How to induce protective humoral immunity against Plasmodium falciparum circumsporozoite protein.
Wahl I; Wardemann H
J Exp Med; 2022 Feb; 219(2):. PubMed ID: 35006242
[TBL] [Abstract][Full Text] [Related]
19. DAF-shielded baculovirus-vectored vaccine enhances protection against malaria sporozoite challenge in mice.
Iyori M; Yamamoto DS; Sakaguchi M; Mizutani M; Ogata S; Nishiura H; Tamura T; Matsuoka H; Yoshida S
Malar J; 2017 Sep; 16(1):390. PubMed ID: 28962615
[TBL] [Abstract][Full Text] [Related]
20. Protective humoral immunity elicited by a needle-free malaria vaccine comprised of a chimeric Plasmodium falciparum circumsporozoite protein and a Toll-like receptor 5 agonist, flagellin.
Carapau D; Mitchell R; Nacer A; Shaw A; Othoro C; Frevert U; Nardin E
Infect Immun; 2013 Dec; 81(12):4350-62. PubMed ID: 24042110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
